Rebound COVID | Allergy Challenges

The JournalFeed podcast for the week of dec 25-29, 2023.

These are summaries from just 2 of the 5 article we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.

Tuesday Spoon Feed:

Treatment of COVID-19 with nirmatrelvir-ritonavir (N-R) was associated with virologic rebound (VR) in a prospective observational trial. Viral loads were high enough to cause transmission, though it remains unclear if certain patients may require longer insolation periods or how to identify those patients without significant retesting.

Friday Spoon Feed:

While removing low risk amoxicillin allergies in the pediatric ED by direct oral challenge (DOC) may be effective, numerous factors play a role in reliable implementation.